Twist Bioscience Corp (TWST)
43.34
+0.55
(+1.29%)
USD |
NASDAQ |
Oct 04, 16:00
43.41
+0.07
(+0.16%)
After-Hours: 20:00
Twist Bioscience Shareholders Equity (Annual): 623.43M for Sept. 30, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | 623.43M |
| September 30, 2022 | 789.38M |
| September 30, 2021 | 580.82M |
| September 30, 2020 | 336.26M |
| Date | Value |
|---|---|
| September 30, 2019 | 152.08M |
| September 30, 2018 | -201.42M |
| September 30, 2017 | -133.36M |
| September 30, 2016 | -76.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
336.26M
Minimum
2020
789.38M
Maximum
2022
582.48M
Average
602.13M
Median
Shareholders Equity (Annual) Benchmarks
| ResMed Inc | 4.864B |
| RxSight Inc | 160.36M |
| Perspective Therapeutics Inc | 75.18M |
| Xtant Medical Holdings Inc | 51.35M |
| Catheter Precision Inc | 21.19M |